Which has preferable valuation & earnings, CI or HUM?

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cigna Group $274.90B 0.26 $5.96B $24.17 11.07 Humana $129.66B 0.35 $1.19B $10.57 36.03

Is CI or HUM more profitable?

Cigna Group has a net margin of 2.27% compared to Humana's net margin of 0.88%. Cigna Group's return on equity of 19.75% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Cigna Group 2.27% 19.75% 5.34% Humana 0.88% 11.20% 3.94%

Does the media prefer CI or HUM?

In the previous week, Humana had 11 more articles in the media than Cigna Group. MarketBeat recorded 35 mentions for Humana and 24 mentions for Cigna Group. Humana's average media sentiment score of 0.49 beat Cigna Group's score of 0.43 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 4 Very Positive mention(s) 6 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Humana 8 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, HUM or CNC?

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.35 $1.19B $10.57 36.03 Centene $194.78B 0.16 -$6.67B -$10.44 N/A

Is HUM or CNC more profitable?

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.88% 11.20% 3.94% Centene -2.51% 12.12% 3.20%

Does the media favor HUM or CNC?

In the previous week, Humana had 30 more articles in the media than Centene. MarketBeat recorded 35 mentions for Humana and 5 mentions for Centene. Centene's average media sentiment score of 0.84 beat Humana's score of 0.49 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 8 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Centene 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, HUM or ELV?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.35 $1.19B $10.57 36.03 Elevance Health $199.13B 0.42 $5.66B $22.50 17.19

Is HUM or ELV more profitable?

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.88% 11.20% 3.94% Elevance Health 2.47% 14.64% 5.22%

Does the media refer more to HUM or ELV?

In the previous week, Humana had 32 more articles in the media than Elevance Health. MarketBeat recorded 35 mentions for Humana and 3 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.02 beat Humana's score of 0.49 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 8 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Elevance Health 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HUM or MOH?

In the previous week, Humana had 29 more articles in the media than Molina Healthcare. MarketBeat recorded 35 mentions for Humana and 6 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 0.85 beat Humana's score of 0.49 indicating that Molina Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 8 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Molina Healthcare 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, UNH or HUM?

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio UnitedHealth Group $447.57B 0.74 $12.06B $15.54 23.67 Humana $129.66B 0.35 $1.19B $10.57 36.03

Does the media favor UNH or HUM?

In the previous week, Humana had 22 more articles in the media than UnitedHealth Group. MarketBeat recorded 35 mentions for Humana and 13 mentions for UnitedHealth Group. Humana's average media sentiment score of 0.49 beat UnitedHealth Group's score of 0.33 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UnitedHealth Group 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Humana 8 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Humana (HUM) Competitors

$381.44 +1.76 (+0.46%)

As of 10:52 AM Eastern

Compare

HUM vs. CI, CNC, ELV, MOH, and UNH

Should you buy Humana stock or one of its competitors? Humana's main competitors and comparable companies include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), and UnitedHealth Group (UNH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Humana compare to Cigna Group?

Cigna Group (NYSE:CI) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Cigna Group has a net margin of 2.27% compared to Humana's net margin of 0.88%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.27%	19.75%	5.34%
Humana	0.88%	11.20%	3.94%

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.26	$5.96B	$24.17	11.07
Humana	$129.66B	0.35	$1.19B	$10.57	36.03

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.3%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Humana pays out 33.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cigna Group has a beta of 0.29, suggesting that its stock price is 71% less volatile than the broader market. Comparatively, Humana has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 0.2% of Humana shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cigna Group currently has a consensus price target of $338.24, suggesting a potential upside of 26.39%. Humana has a consensus price target of $408.61, suggesting a potential upside of 7.28%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts plainly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Humana	1 Sell rating(s)	14 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.47

In the previous week, Humana had 11 more articles in the media than Cigna Group. MarketBeat recorded 35 mentions for Humana and 24 mentions for Cigna Group. Humana's average media sentiment score of 0.49 beat Cigna Group's score of 0.43 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	4 Very Positive mention(s)	6 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Humana	8 Very Positive mention(s)	7 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cigna Group beats Humana on 12 of the 18 factors compared between the two stocks.

How does Humana compare to Centene?

Humana (NYSE:HUM) and Centene (NYSE:CNC) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.35	$1.19B	$10.57	36.03
Centene	$194.78B	0.16	-$6.67B	-$10.44	N/A

In the previous week, Humana had 30 more articles in the media than Centene. MarketBeat recorded 35 mentions for Humana and 5 mentions for Centene. Centene's average media sentiment score of 0.84 beat Humana's score of 0.49 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	8 Very Positive mention(s)	7 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Centene	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Humana has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Centene has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Centene	-2.51%	12.12%	3.20%

Humana presently has a consensus target price of $408.61, suggesting a potential upside of 7.28%. Centene has a consensus target price of $70.05, suggesting a potential upside of 13.42%. Given Centene's higher probable upside, analysts plainly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	14 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.47
Centene	2 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.43

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.35	$1.19B	$10.57	36.03
Elevance Health	$199.13B	0.42	$5.66B	$22.50	17.19

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Elevance Health	2.47%	14.64%	5.22%

Humana has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Humana pays out 33.5% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana currently has a consensus price target of $408.61, indicating a potential upside of 7.28%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 14.01%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	14 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.47
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

In the previous week, Humana had 32 more articles in the media than Elevance Health. MarketBeat recorded 35 mentions for Humana and 3 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.02 beat Humana's score of 0.49 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	8 Very Positive mention(s)	7 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elevance Health	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elevance Health beats Humana on 14 of the 18 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Humana has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Humana has a net margin of 0.88% compared to Molina Healthcare's net margin of -0.02%. Humana's return on equity of 11.20% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Molina Healthcare	-0.02%	3.73%	0.97%

Humana currently has a consensus target price of $408.61, indicating a potential upside of 7.28%. Molina Healthcare has a consensus target price of $202.44, indicating a potential upside of 9.60%. Given Molina Healthcare's higher possible upside, analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	14 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.47
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.18

In the previous week, Humana had 29 more articles in the media than Molina Healthcare. MarketBeat recorded 35 mentions for Humana and 6 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 0.85 beat Humana's score of 0.49 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	8 Very Positive mention(s)	7 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Molina Healthcare	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.35	$1.19B	$10.57	36.03
Molina Healthcare	$45.43B	0.21	$472M	-$0.18	N/A

92.4% of Humana shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Humana beats Molina Healthcare on 11 of the 17 factors compared between the two stocks.

How does Humana compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by company insiders. Comparatively, 0.2% of Humana shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

UnitedHealth Group presently has a consensus target price of $465.75, suggesting a potential upside of 26.61%. Humana has a consensus target price of $408.61, suggesting a potential upside of 7.28%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, research analysts clearly believe UnitedHealth Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	0 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.71
Humana	1 Sell rating(s)	14 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.47

UnitedHealth Group has a net margin of 3.14% compared to Humana's net margin of 0.88%. UnitedHealth Group's return on equity of 16.53% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	3.14%	16.53%	5.43%
Humana	0.88%	11.20%	3.94%

In the previous week, Humana had 22 more articles in the media than UnitedHealth Group. MarketBeat recorded 35 mentions for Humana and 13 mentions for UnitedHealth Group. Humana's average media sentiment score of 0.49 beat UnitedHealth Group's score of 0.33 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Humana	8 Very Positive mention(s)	7 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

UnitedHealth Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Humana has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.5%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Humana pays out 33.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$447.57B	0.74	$12.06B	$15.54	23.67
Humana	$129.66B	0.35	$1.19B	$10.57	36.03

Summary

UnitedHealth Group beats Humana on 12 of the 19 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUM vs. The Competition

Export

Metric	Humana	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$45.71B	$9.59B	$7.22B	$22.64B
Dividend Yield	0.93%	2.60%	2.53%	3.74%
P/E Ratio	36.01	33.83	272.64	27.58
Price / Sales	0.35	4.88	607.49	20.54
Price / Cash	15.86	120.27	77.38	39.56
Price / Book	2.58	5.12	10.88	4.62
Net Income	$1.19B	$315.68M	$3.50B	$1.08B
7 Day Performance	-4.09%	-3.34%	-2.03%	-1.52%
1 Month Performance	-4.81%	-3.28%	-6.43%	-5.48%
1 Year Performance	48.28%	7.89%	8.95%	5.05%

Humana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUM Humana	4.4189 of 5 stars	$381.44 +0.5%	$408.61 +7.1%	+53.6%	$45.83B	$129.66B	36.11	67,060	Trending News Analyst Revision
CI Cigna Group	4.9375 of 5 stars	$274.41 -0.3%	$337.10 +22.8%	-7.9%	$72.51B	$274.90B	11.35	67,700	Analyst Forecast
CNC Centene	3.8502 of 5 stars	$65.08 0.0%	$70.05 +7.6%	+70.4%	$32.15B	$202.94B	N/A	61,100
ELV Elevance Health	4.6952 of 5 stars	$409.43 -0.4%	$440.90 +7.7%	+14.8%	$88.79B	$199.13B	18.20	97,100	Positive News
MOH Molina Healthcare	2.6886 of 5 stars	$197.70 -1.5%	$202.44 +2.4%	-6.2%	$10.32B	$44.52B	N/A	19,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HUM) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Summary

How does Humana compare to Centene?

Summary

How does Humana compare to Elevance Health?

Summary

How does Humana compare to Molina Healthcare?

Summary

How does Humana compare to UnitedHealth Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Is CI or HUM more profitable?

Which has preferable valuation & earnings, CI or HUM?

Is CI or HUM a better dividend stock?

Which has more risk and volatility, CI or HUM?

Do insiders & institutionals believe in CI or HUM?

Do analysts rate CI or HUM?

Does the media prefer CI or HUM?

Summary

How does Humana compare to Centene?

Which has higher earnings & valuation, HUM or CNC?

Does the media favor HUM or CNC?

Do insiders and institutionals have more ownership in HUM or CNC?

Which has more volatility & risk, HUM or CNC?

Is HUM or CNC more profitable?

Do analysts recommend HUM or CNC?

Summary

How does Humana compare to Elevance Health?

Which has preferable earnings & valuation, HUM or ELV?

Is HUM or ELV more profitable?

Which has more volatility & risk, HUM or ELV?

Do institutionals & insiders have more ownership in HUM or ELV?

Is HUM or ELV a better dividend stock?

Do analysts recommend HUM or ELV?

Does the media refer more to HUM or ELV?

Summary

How does Humana compare to Molina Healthcare?

Which has more risk & volatility, HUM or MOH?

Is HUM or MOH more profitable?

Do analysts rate HUM or MOH?

Does the media refer more to HUM or MOH?

Which has stronger earnings & valuation, HUM or MOH?

Do institutionals & insiders hold more shares of HUM or MOH?

Summary

How does Humana compare to UnitedHealth Group?

Do insiders and institutionals hold more shares of UNH or HUM?

Do analysts recommend UNH or HUM?

Is UNH or HUM more profitable?

Does the media favor UNH or HUM?

Which has more volatility & risk, UNH or HUM?

Is UNH or HUM a better dividend stock?

Which has higher earnings and valuation, UNH or HUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools